$CBRS

Cerebras Stock (CBRS) Falls as Earnings Highlight $25.4 Billion Backlog and Capacity Challenge

Cerebras Systems (CBRS) shares reversed after earnings, rising 11.6% in the regular session but falling more than 12% after results. Q2 core revenue was $209.9M (103% YoY) and adjusted loss was $0.05 vs $0.17 expected. FY2026 core revenue guidance rose to $880M-$890M; performance obligations were $25.4B. AMD and Amazon partnerships were cited.

Original reporting
Published Aug 12, 2026, 9:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:43 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cerebras Stock (CBRS) Falls as Earnings Highlight $25.4 Billion Backlog and Capacity Challenge — source image
Decision brief

The 30-second read

$CBRSNeutralMed
01

Why it matters

The key trade tension is whether the raised guidance and backlog translate into near-term revenue, given the after-hours selloff and the stated focus on commissioning, production, and cash requirements.

02

Market read

Earnings beat plus guidance raise were not enough to prevent a sharp after-hours reversal, making capacity ramp and order conversion the immediate driver for CBRS positioning.

03

What to watch

The article notes different definitions for core revenue versus reported sales; traders may be misinterpreting the beat and guidance if they compare the wrong metrics.

Relevance 8/10Novelty 7/10Timing: after-hours reaction to Q2 earnings and updated 2026 core revenue outlook (Aug 12)

Background

Cerebras’ earnings highlighted a large backlog and a modest increase to 2026 core revenue guidance, alongside commentary on expanding data-center capacity and manufacturing.

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras reported Q2 results and raised 2026 core revenue guidance, but shares reversed after-hours as investors questioned order-to-revenue conversion.

Expected impact

Near-term volatility likely as traders reprice 2026 delivery risk versus the raised midpoint and $25.4B backlog multiple.

Evidence & confidence

The article provides both the positive datapoints (Q2 beat, guidance raise, $25.4B performance obligations) and the negative market reaction (over 12% drop after-hours, reversal of earlier gains). It also flags upcoming focus areas: data-center commissioning, manufacturing production, and cash needs.

Market effects

AI inference hardware names may see read-across trading on backlog-to-revenue conversion and capacity ramp credibility.

Limited direct regional impact; primarily US-listed AI semiconductor/infrastructure sentiment.

Backlog and capacity narratives can influence global AI infrastructure capex expectations, but the article is company-specific.

Counterpoint

The $25.4B performance obligations multiple may be a leading indicator of demand, and the after-hours drop could be an overreaction to guidance magnitude rather than delivery capability.

Key entities

  • Cerebras Systems, Inc.

    NASDAQ-listed AI chip company reporting Q2 results, raising 2026 core revenue outlook, and disclosing $25.4B performance obligations.

  • Andrew Feldman

    CEO quoted on demand for fast inference and capacity/manufacturing expansion.

  • Bob Komin

    CFO quoted on expectations to more than triple revenue in 2027.

  • Advanced Micro Devices, Inc.

    Partner mentioned as intending to integrate Helios systems with Cerebras chips.

  • Amazon.com, Inc.

    Partner mentioned as joining forces with Cerebras to develop an AWS inference solution.

Related articles

$CBRSMedAI 8/10

Why Cerebras Systems Stock Just Sank

Cerebras Systems (CBRS) shares fell about 11.9% on Thursday after its Q2 report, which came in below Wall Street expectations. The company posted a net loss of $2.98 per share on revenue of $180.11 million, with revenue about $13.4 million under forecasts. It raised full-year sales and margin targets.

$CBRSMed

Cerebras Stock Slumps After Earnings -- Analysts See 'Buying Opportunity'

Cerebras Systems (CBRS) shares dropped after its Q2 results. The company reported $180.1M revenue, up over 70% YoY, with an adjusted loss of $6.91M versus about $41M expected, and a net loss of $450.5M. It raised FY2026 core revenue guidance to $880M-$890M and Q3 to $214M-$216M. Analysts kept bullish stances, raising price targets (Wedbush to $290, Morgan Stanley to $279) despite the selloff.

$CBRSMedAI 8/10

Cerebras Systems’ Stock Falls 17% On Mixed Financial Results

Cerebras Systems (CBRS) shares fell 17% after its second earnings report as a public company. The company posted EPS loss of -$0.05 vs -$0.17 expected, but revenue was $180M vs $194M forecast. Net loss was $450.5M. It guided current-quarter revenue to $214M-$216M and full-year to $880M-$890M. Cerebras cited $25.4B backlog.

$CBRSMedAI 8/10

Cerebras Raised Guidance but Still Lost a Fifth of Its Value

Cerebras Systems (CBRS) shares fell premarket after Q2 GAAP revenue of $180.1M missed the $194M consensus. The company reported $209.9M core revenue, excluding pass-through revenue and adding back warrant amortization. Cloud and other services rose to $126.0M, while hardware fell to $54.1M. GAAP net loss was $450.5M ($2.98/share). Full-year core guidance increased to $880M-$890M.